You have access
Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3Kδ
Rodger A. Allen, Daniel C. Brookings, Mark J. Powell, Jean Delgado, Lindsay K. Shuttleworth, Mark Merriman, Ian J. Fahy, Roohi Tewari, John P. Silva, Louise J. Healy, Gareth C. G. Davies, Breda Twomey, Rona M. Cutler, Apoorva Kotian, Andrea Crosby, Gillian McCluskey, Gillian F. Watt and Andrew Payne
Journal of Pharmacology and Experimental Therapeutics June 2017, 361 (3) 429-440; DOI: https://doi.org/10.1124/jpet.116.237347